Reduction in oxidative stress and modulation of heart failure subsequent to myocardial infarction in rats

Experimental and Clinical Cardiology

Volumn 10, Issue 3, 2005, Pages 146-153

  Hill, Michael F ^a,b   Palace, Vince P ^a,b   Kaur, Kuljeet ^a,b   Kumar, Dinender ^a,b   Khaper, Neelam ^a,b   Singal, Pawan K ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Heart failure; Myocardial infarction; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYANOSIS; DIET SUPPLEMENTATION; DISEASE CONTROL; DYSPNEA; ENZYME ACTIVITY; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; LETHARGY; LIPID PEROXIDATION; MALE; MUSCLE LEVEL; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; RAT; SURGICAL TECHNIQUE; SYSTOLE;

EID: 24144490641     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Anversa P, Olivetti G, Meggs LG, Sonnenblick EH, Capasso JM. Cardiac anatomy and ventricular loading after myocardial infarction. Circulation 1993;87:VII22-7.
2. Francis GS, McDonald KM, Cohn JN. Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention. Circulation 1993;87:IV90-6.
3. Ferguson DW. Sympathetic mechanisms in heart failure. Pathophysiological and pharmacological implications. Circulation 1993;87:VII68-75.
4. Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy. Circulation 1994;89:2829-35.
5. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28:506-14.
6. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: Which role for oxidative stress? Metabolism 1995;44:363-8.
7. Gupta M, Singal PK. Higher antioxidant capacity during a chronic stable heart hypertrophy. Circ Res 1989;64:398-406.
8. Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol 1994;266:H1280-5.
9. Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N. Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster. J Am Coll Cardiol 1987;10:1128-38.
10. Singh RB, Niaz MA, Rastogi SS, Rastogi S. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3). Am J Cardiol 1996;77:232-6.
11. McMurray J, Mclay J, Chopra M, Bridges A, Belch JJ. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;65:1261-2.
12. Diaz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E, Hernandez-Lopez E. Increased malonidaldehyde in peripheral blood of patients with congestive heart failure. Am Heart J 1996;131:146-52.
13. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trail of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
14. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:154-60.
15. Lonn E, Bosch J, Yusuf S, et al; HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. JAMA 2005;293:1338-47.
16. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-20.
17. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996;148:291-300.
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterixation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
19. Clairborne A. Catalase activity. In: Greenwald RA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton, Florida: CRC Press, 1985:283-4.
20. Palace VP, Brown SB. HPLC determination of tocopherol, retinol, dehydroretinol and retinyl palmitate in tissues of lake char (Salvelinus namaycush) exposed to coplanar 3,3′,4,4′,5-pentachlorobiphenyl. Environ Toxicol Chem 1994; 13:473-6.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
22. Shah PK, Maddahi J, Berman DS, Pichler M, Swan HJ. Scintigraphically detected predominant right ventricular dysfunction in acute myocardial infarction: Clinical and hemodynamic correlates and implications for therapy and prognosis. J Am Coll Cardiol 1985;6:1264-72.
23. Bueno H, Lopez-Palop R, Bermejo J, Lopez-Sendon JL, Delcan JL. In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation 1997;96:436-41.
24. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993;328:981-8.
25. Lloyd EA, Gersh BJ, Kennelly BM. Hemodynamic spectrum of "dominant" right ventricular infarction in 19 patients. Am J Cardiol 1981;48:1016-22.
26. Goldstein JA, Vlahakes GJ, Verrier ED, et al. The role of right ventricular systolic dysfunction and elevated intrapericardial pressure in the genesis of low cardiac output in experimental right ventricular infarction. Circulation 1982;65:513-22.
27. Stringer MD, Gorog PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. BMJ 1989;298:281-4.
28. Weitz Z, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL. High breath pentane concentrations during acute myocardial infarction. Lancet 1991;337:933-5.
29. Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, Zarling EJ. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radical Biol Med 1993;14:643-7.
30. Charney RH, Levy DK, Kalman J, et al. Free radical activity increases with NYHA class in congestive heart failure. J Am Coll Cardiol 1997;29(Suppl):102A. (Abst)
31. Lafont A, Marwick TH, Chisolm GM, Van Lente F, Vaska KJ, Whitlow PL. Decreased free radical scavengers with reperfusion after coronary angioplasty in patients with acute myocardial infarction. Am Heart J 1996;131:219-23.
32. Weisel RD, Mickle DA, Finkle CD, et al. Myocardial free-radical injury after cardioplegia. Circulation 1989;80:III14-8.
33. Ferreira RF, Milei J, Llesuy S, et al. Antioxidant action of vitamins A and E in patients submitted to coronary artery bypass surgery. Vasc Surg 1991;25:191-5.
34. Ghatak A, Brar MJ, Agarwal A, et al. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol 1996;57:119-27.
35. Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidant vitamins in relations to ischemic heart disease and cancer. Am J Clin Nutr 1987;45:1368-77.
36. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
37. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
38. Danelisen I, Palace V, Lou H, Singal PK. Maintenance of myocardial levels of vitamin A in heart failure due to adriamycin. J Mol Cell Cardiol 2002;34:789-95.
39. Packer L. Interactions among antioxidants in health and disease: Vitamin E and its redox cycle. Proc Soc Exp Biol Med 1992;200:271-6.
40. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr 1991;10:466-73.
41. Dowd P, Zheng ZB. On the mechanism of the anticlotting action of vitamin E quinone. Proc Natl Acad Sci USA 1995;92:8171-5.
42. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Luscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992;70:1191-7.
43. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:889-906.
44. Ozer NK, Boscoboinik D, Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int 1995;35:117-24.
45. Stauble B, Boscoboinik D, Tasinato A, Azzi A. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells. Eur J Biochem 1994;226:393-402.
46. Chatelain E, Boscoboinik DO, Bartoli GM, et al. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochem Biophys Acta 1993;1176:83-9.
47. Sebbag L, Forrat R, Canet E, Renaud S, Delaye J, de Lorgeril M. Effects of dietary supplementation with alpha-tocopherol on myocardial infarct size and ventricular arrhythmias in a dog model of ischemia-reperfusion. J Am Coll Cardiol 1994;24:1580-5.